CRISPR Therapeutics AG
CRSP
Market Cap$4.73B
Close$
$-32.84
159% downside
Current Fair Value
159% downsideOvervalued by 159% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.73 Billion |
|---|---|
| Enterprise Value | $2.62 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.71 |
| Beta | 0.0 |
| Outstanding Shares | 84,918,093 |
| Avg 30 Day Volume | 1,436,104 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -21.77 |
|---|---|
| PEG | -18.19 |
| Price to Sales | 18.56 |
| Price to Book Ratio | 2.32 |
| Enterprise Value to Revenue | 9.64 |
| Enterprise Value to EBIT | -8.77 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About CRISPR Therapeutics AG
CEO: Samarth Kulkarni